Right Medicine.
Right From The Start.®


Are all of the
Medications I take
Right For Me?


Why is it so
hard to get my
dosing right?


Could I have
avoided negative
side effects?


Trial and error to
get my medications


Why can't we get
my child's ADHD
medication right?


Getting started with Rxight

is as easy as


      Obtain your medication therapy blueprint




      Improve patient medication care plans




      Apply PGx for improved patient outcomes



      Introducing Rxight, pharmacogenetic testing to help patients, pharmacists, and prescribers get the right medicine, right from the start.®

      CLIA Certified Pharmacogenetic Testing

      Rxight™ is simple, affordable and the most comprehensive DNA drug sensitivity program available.  Rxight™ covers over 200 prescription and OTC medications, and as such allows prescribers to incorporate an individual’s genetic profile to make better and more informed medication therapy decisions. For patients, it’s the idea of precision medicine in its most personalized form. For pharmacists, it means knowing your customers have the medications best suited for them. And for providers, it brings evidence-based medicine, pharmacogenetics, to the patient level for better, quicker outcomes when prescribing medication.

      Pharmacogenetic Testing for Fewer Adverse Drug Reactions

      One of the key benefits of pharmacogenetic testing is the potential for the DNA test to prevent adverse drug reactions through targeted treatments. Pharmacogenetic testing allows healthcare providers to further understand how patients will process and metabolize certain prescription and OTC medications based on the patient’s genetic profile.


      Pharmacogenetic testing offers a comprehensive analysis of the genetic variations of an individual patient, creating a stronger foundation upon which a drug treatment plan may be structured. Equipped with pharmacogenetic insight, prescribers are better able to avoid prescribing medications to their patients that could result in an adverse reaction, and prescribe an optimized medication plan developed based on their patient’s genetic fingerprint.


      While there are numerous ways adverse drug reactions can be reduced within the healthcare community, pharmacogenetic testing and a focus on precision medicine can provide the necessary framework for medication optimization and the prevention of adverse drug reactions across the board.


      What if figuring out the right dose of medicine was as simple as taking our temperature? And that's the promise of precision medicine — delivering the right treatments, at the right time, every time to the right person (January 30, 2015 - remarks on Precision Medicine).

      Barack ObamaPresident of the United States

      We want to help healthcare providers maximize their clinical care, through Rxight™ they can be further assured that the medications they prescribe are tailored for their patients and can reduce the risk of side effects.

      Denis GrizeljCo-Founder/CEO of MD Labs

      We can identify how genetic variation can lead to unintended medication consequences that may contribute to patients not taking their medication as prescribed and also help reduce long-term health care costs of medications.

      Dr. Amina Abubakar2016 PDS Entrepreneur of the Year

      American Medical Association – Pharmacogenomics

      May 27, 2016

      genetic testing

      A Call to Action: Protecting US Citizens From Inappropriate Medication Use

      May 16, 2016

      genetic testing

      Warfarin (Coumadin) Black Box Warning

      May 16, 2016

      genetic testing

      95% of people have genetic variations that affect if a drug will work for them or not

      March 14, 2016

      precision medicine

      The White House Explains Precision Medicine

      March 12, 2016

      genetic testing

      Personalized Pain Medicine: Pharmacogenetic Testing for Pain and Opioid Addiction

      September 30, 2015

      genetic testing

      Plavix (Clopidogrel) Black Box Warning

      June 1, 2015

      precision medicine

      The National Institutes of Health’s Precision Medicine Initiative

      March 30, 2014